Fresenius Kabi

Director Early-Stage Portfolio Management (m/f/d)

Fresenius Kabi  •  Federal Republic of Germany (Onsite)  •  3 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

As Director Early-Stage Portfolio Management (m/f/d), you will play a key role within our Marketing, Strategy & Portfolio team. You will shape the commercial strategy of early-stage products and support strategic portfolio decisions across our global Biopharma business. Working with development teams, Business Development, Finance and regional stakeholders, you will translate market insights into robust business strategies.

This position can be based in Germany (Bad Homburg) or Spain (Madrid or Barcelona).

Your Responsibilities:

  • Lead the development of the early-stage portfolio on behalf of the Marketing, Strategy & Portfolilo team, as a core member of cross-functional product development teams
  • Define target product profiles and support their cross-functional alignment
  • Develop sales forecasts, SG&A cost estimates and commercial assumptions for early-stage products
  • Generate competitive intelligence, market research and business insights to support strategic decision-making
  • Ensure that commercial perspectives are incorporated into development milestones and early product strategies
  • Develop business cases for potential in-licensing and out-licensing opportunities in collaboration with Business Development, Finance and regional teams
  • Contribute commercial expertise to due diligence processes and lead pitch presentations for potential business partners
  • Lead and support cross-functional evaluations of portfolio strategies and potential additions to the development pipeline
  • Assess and prioritize life cycle management opportunities for late-stage products
  • Support Biopharma leadership in developing mid- and long-term strategies, strategic projects, management reporting and executive presentations

Your Qualifications:

  • University degree, preferably in a scientific discipline, or an equivalent qualification; a postgraduate degree such as an MA, MSc, MBA or PhD is highly desirable
  • At least ten years of relevant experience in portfolio management and strategy development
  • Strong expertise in biosimilar development as well as the biosimilar market landscape and dynamics, particularly in the US and Europe
  • Proven experience in competitive intelligence, business insights, analytics and primary or secondary market research
  • Solid expertise in sales and cost forecasting as well as P&L-related reporting
  • Robust understanding of pharmaceutical product development and the ability to influence early-stage development and commercial strategy
  • Ability to manage complexity and translate data, market insights and conceptual ideas into clear strategies and recommendations
  • Strong cross-functional leadership and collaboration skills in an international environment
  • Proven project management skills and experience managing multiple external vendors and priorities
  • Excellent communication and presentation skills, high attention to detail and fluency in written and spoken English; additional languages are an advantage

Drive the future of our Biopharma - join #futurefresenius and apply now through our online portal.

Fresenius Kabi

About Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.

Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.

User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions

Imprint: www.fresenius-kabi.com/imprint

Industry
Pharmaceutical & Medicine
Company Size
10,000+ employees
Headquarters
Bad Homburg, DE
Year Founded
Unknown
Social Media